Chemical Formula: C14H22N2O2
Chemical Formula C14H22N2O2
Found 55 metabolite its formula value is C14H22N2O2
Rivastigmine
Rivastigmine is only found in individuals that have used or taken this drug. It is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimers type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.Rivastigmine is a carbamate derivative that is structurally related to physostigmine, but not to donepezil and tacrine. The precise mechanism of rivastigmine has not been fully determined, but it is suggested that rivastigmine binds reversibly with and inactivates chlolinesterase (eg. acetylcholinesterase, butyrylcholinesterase), preventing the hydrolysis of acetycholine, and thus leading to an increased concentration of acetylcholine at cholinergic synapses. The anticholinesterase activity of rivastigmine is relatively specific for brain acetylcholinesterase and butyrylcholinesterase compared with those in peripheral tissues. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2844 EAWAG_UCHEM_ID 2844; CONFIDENCE standard compound D020011 - Protective Agents D004791 - Enzyme Inhibitors
3-Hydroxylidocaine
3-Hydroxylidocaine is a metabolite of lidocaine. Lidocaine, Xylocaine, or lignocaine is a common local anesthetic and antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning and pain from skin inflammations, injected as a dental anesthetic or as a local anesthetic for minor surgery. (Wikipedia)
Naepaine
C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent
Lidocaine N-oxide
CONFIDENCE Transformation product with Reference Standard (Level 1); INTERNAL_ID 801 INTERNAL_ID 801; CONFIDENCE Transformation product with Reference Standard (Level 1) CONFIDENCE standard compound; EAWAG_UCHEM_ID 3279 CONFIDENCE standard compound; INTERNAL_ID 2114
Acetamide, 2-(diethylamino)-N-(4-hydroxy-2,6-dimethylphenyl)-
RIVASTIGMINE
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors N - Nervous system > N06 - Psychoanaleptics > N06D - Anti-dementia drugs > N06DA - Anticholinesterases D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C471 - Enzyme Inhibitor > C47792 - Acetylcholinesterase Inhibitor D020011 - Protective Agents D004791 - Enzyme Inhibitors
tert-butyl N-[2-amino-2-(2-methylphenyl)ethyl]carbamate
N-METHYL-N-[3-(2-MORPHOLIN-4-YLETHOXY)BENZYL]AMINE
2-[4-(2-AMINO-ETHYL)-PHENOXY]-N,N-DIETHYL-ACETAMIDE
tert-butyl 2-cyano-7-azaspiro[3.5]nonane-7-carboxylate
TERT-BUTYL 2-(AMINOMETHYL)-4-METHYLBENZYLCARBAMATE
4-{[(3-Dimethylamino-propyl)-methyl-amino]-methyl}-benzoic acid
2-Methyl-2-propanyl (3-amino-1-phenylpropyl)carbamate
2-(Diethylamino)-N-(4-hydroxy-2,6-dimethylphenyl)acetamide
(1s,2s,9s,10r,14r)-6-oxo-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadecan-14-ium-14-olate
(1r,2s,9r,10s,11s)-11-hydroxy-7,14-diazatetracyclo[7.6.1.0²,⁷.0¹⁰,¹⁴]hexadecan-6-one
5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-A.1',2'-D]pyrazine
{"Ingredient_id": "HBIN010946","Ingredient_name": "5,10-diethoxy-2,3,7,8-tetrahydro-1H,6H-dipyrrolo[1,2-A.1',2'-D]pyrazine","Alias": "NA","Ingredient_formula": "C14H22N2O2","Ingredient_Smile": "CCOC1=C2CCCN2C(=C3N1CCC3)OCC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "40824","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}